Mounjaro vs Ozempic – Which Works Better for Weight Loss in 2025?

Gaia Service
Aug 11
2 min read

Quick Answer

Mounjaro (tirzepatide) and Ozempic (semaglutide) are weekly injections originally for type 2 diabetes, now widely used for weight loss.

Mounjaro may lead to greater weight loss (~20–22% body weight) vs Ozempic (~15%).
Both are effective, safe under medical supervision, and can be costly in the U.S.💊 Check licensed Mounjaro supply with fast delivery here.

How They Work

Ozempic: GLP-1 receptor agonist — reduces appetite, slows digestion, controls blood sugar.
Mounjaro: Dual GLP-1 + GIP receptor agonist — may offer stronger appetite suppression and improved metabolism.

Clinical Weight Loss Results

Drug	Avg. Weight Loss	Duration in Trials
Mounjaro (15 mg)	20–22%	72 weeks
Ozempic/Wegovy (2.4 mg)	~15%	68 weeks

Note: Results vary per individual and require diet & lifestyle support.

Side Effects

Common for both:

Nausea
Digestive discomfort
Fatigue

Mounjaro may cause slightly more gastrointestinal side effects early on, but symptoms often improve over time.

Cost & Access

USA retail price: Often $1,000+ per month without insurance.
International sourcing: Patients can save up to 80% by using licensed overseas pharmacies.

💊 Order Mounjaro online from a trusted, licensed source here.

Which Should You Choose?

Choose Mounjaro if aiming for maximum weight loss results.
Choose Ozempic if you’ve had success with it or prefer a single-action GLP-1 approach.
Always consult your doctor before switching medications.

Final Takeaway

Both medications are proven, but Mounjaro’s dual-action formula may provide a slight advantage for weight loss.If cost is a barrier, international licensed pharmacies can help patients access authentic medication safely at a lower price.

💊 See Mounjaro options now here.

Internal Linking Suggestions: